Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4065603
Max Phase: Preclinical
Molecular Formula: C24H34INO4
Molecular Weight: 527.44
Molecule Type: Small molecule
Associated Items:
ID: ALA4065603
Max Phase: Preclinical
Molecular Formula: C24H34INO4
Molecular Weight: 527.44
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCCCCCC[C@H]1O[C@@H]1C(OC(=O)c1ccc(I)cc1)C(=O)NC1CCCCC1
Standard InChI: InChI=1S/C24H34INO4/c1-2-3-4-5-9-12-20-21(29-20)22(23(27)26-19-10-7-6-8-11-19)30-24(28)17-13-15-18(25)16-14-17/h13-16,19-22H,2-12H2,1H3,(H,26,27)/t20-,21+,22?/m1/s1
Standard InChI Key: JGYPSIUZIQZSFE-LKXRKSRJSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 527.44 | Molecular Weight (Monoisotopic): 527.1533 | AlogP: 5.39 | #Rotatable Bonds: 11 |
Polar Surface Area: 67.93 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: 2 | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 13.68 | CX Basic pKa: | CX LogP: 6.81 | CX LogD: 6.81 |
Aromatic Rings: 1 | Heavy Atoms: 30 | QED Weighted: 0.18 | Np Likeness Score: 0.05 |
1. Dos Santos DA, Deobald AM, Cornelio VE, Ávila RMD, Cornea RC, Bernasconi GCR, Paixão MW, Vieira PC, Corrêa AG.. (2017) Asymmetric synthesis and evaluation of epoxy-α-acyloxycarboxamides as selective inhibitors of cathepsin L., 25 (17): [PMID:28720327] [10.1016/j.bmc.2017.06.048] |
2. Silva TL, Dos Santos DA, de Jesus HCR, Brömme D, Fernandes JB, Paixão MW, Corrêa AG, Vieira PC.. (2020) Green asymmetric synthesis of epoxypeptidomimetics and evaluation as human cathepsin K inhibitors., 28 (15): [PMID:32631567] [10.1016/j.bmc.2020.115597] |
Source(1):